Correction: Oral Intake of Royal Jelly Has Protective Effects against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial. Medicines, 2019, 6, 2

Detalles Bibliográficos
Autores principales: Araki, Kyohei, Miyata, Yasuyoshi, Ohba, Kojiro, Nakamura, Yuichiro, Matsuo, Tomohiro, Mochizuki, Yasushi, Sakai, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699318/
https://www.ncbi.nlm.nih.gov/pubmed/33228263
http://dx.doi.org/10.3390/medicines7110071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699318/
https://www.ncbi.nlm.nih.gov/pubmed/33228263
http://dx.doi.org/10.3390/medicines7110071

Ejemplares similares